The Cannabis ETF (NYSE:THCX) is down roughly 62% year-to-date, as emerging markets have received the biggest brunt of the market downfall since the beginning of the year.
Although directly investing in a company that only deals with cannabis-related products may be fruitful, it may be safer to invest in an established firm with already strong brands looking to diversify in the cannabis space.
